Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07818395) titled 'Spatial Multi-Omics of Perineural Invasion Microenvironment and Prognosis in Prostate Cancer' on Sept. 8.

Study Type: Observational

Primary Sponsor: Anhui Medical University

Condition: Prostate Cancer Adenocarcinoma

Intervention: Diagnostic Test: Multi-omics profiling

Recruitment Status: Not recruiting

Date of First Enrollment: October 1, 2026

Target Sample Size: 120

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07818395

Published by HT Digital Content Services with permission from Health Daily Digest....